Agenus provides corporate update and second quarter 2022 financial report

Lexington, mass., aug. 09, 2022 (globe newswire) -- agenus inc. (nasdaq: agen), an immuno-oncology company with an extensive pipeline of therapeutics designed to activate the immune response to cancers and infections, today provided a corporate update and reported financial results for the second quarter of 2022.
AGEN Ratings Summary
AGEN Quant Ranking